Clinical Trials Browser

Approved for marketing × OTHER × Recurrence × Clear all

NCT01377532 2020-05-06

Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma

Approved for marketing

Neoplasms, Paraganglioma, Pheochromocytoma, Recurrence

NCT02355054 2017-01-20

Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access Study

Approved for marketing

Prostatic Neoplasms, Recurrence